NSC23005 sodium is primarily utilized in biomedical research, particularly in studies focused on cancer therapy. It acts as an inhibitor targeting specific pathways involved in tumor growth and proliferation. Researchers employ this compound to investigate its efficacy in halting the progression of various cancer types, often in preclinical models. Its application extends to understanding cellular mechanisms and evaluating potential therapeutic strategies. Additionally, NSC23005 sodium is used in drug development pipelines to assess its safety, pharmacokinetics, and pharmacodynamics, contributing to the advancement of novel anticancer agents.